Clinical Trial Update: Treatment of Mild to Moderate Joint Pain in Patients With Chronic Plaque Psoriasis Receiving Efalizumab [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated treatment of mild-to-moderate joint pain in patients with chronic plaque psoriasis who are receiving efalizumab. The trial status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthralgia
• Arthritis
• Plaque Psoriasis

Drugs mentioned

• Raptiva (efalizumab)

Snippet

Sponsor: Probity Medical Research | Conditions: Arthritis, Arthralgia | Phase 4 | Status: COMPLETED